Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Spanish investigators discover novel antihypertensive agent

Nov. 21, 1996

Chiesi reports pharmacological profile of CHF-2363

Nov. 21, 1996

Merck & Co. launches Hyzaar in France

Nov. 21, 1996

Potent and selective PAF antagonist from Uriach

Nov. 21, 1996

TBC-11251 enters clinical trials

Nov. 20, 1996

Completion of phase IIa trials with CytoTAb in sepsis

Nov. 19, 1996

ET antagonists revealed by SmithKline Beecham

Nov. 19, 1996

Hyal and The Hospital for Sick Children vascular disease collaboration

Nov. 15, 1996

Cypros acquires well-established Rx for esophageal varices

Nov. 15, 1996

Human pharmacokinetic/pharmacodynamic studies on bosentan

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...